Join
Live feed
·
INSIDERFilingvia Quantisnow
Ironwood Pharmaceuticals Inc. logo

SVP, Chief Business Officer Davis Andrew sold $21,869 worth of shares (5,360 units at $4.08), decreasing direct ownership by 2% to 284,685 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IRWD· Ironwood Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRWD (Ironwood Pharmaceuticals Inc.) and more on Quantisnow.